Annabel E. K. Grinbergs

Dual-5 (cid:2) -Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man

W. Dunn, L. Hodson, N. Nikolaou, 2015 .

Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man

W. Dunn, L. Hodson, N. Nikolaou, 2015, The Journal of clinical endocrinology and metabolism.

Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response

M. Drayson, A. Cunningham, D. Wraith, 2021, BMJ Open Respiratory Research.

Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response

M. Drayson, A. Cunningham, D. Wraith, 2020, medRxiv.

Dual 5-[alpha] reductase inhibition promotes hepatic lipid accumulation in man as a result of changes to lipid metabolism in adipose tissue and the liver

W. Dunn, L. Hodson, N. Nikolaou, 2015 .

Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man

L. Hodson, N. Nikolaou, M. Armstrong, 2015, The Journal of clinical endocrinology and metabolism.